# First Wave Bio, Inc. — Form D

First Wave Bio, Inc. of New York, NY, a company, filed a Form D exempt-offering notice with the SEC on 2019-08-19. The offering totals $5.0M, of which $2.6M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2019-08-19
- Form: D
- Accession: 0001783499-19-000005
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $5.0M
- Amount sold: $2.6M
- Remaining: $2.4M
- Investors: 21
- Date of first sale: 2018-09-06
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-346884

## Issuer

- Name: First Wave Bio, Inc.
- CIK: 0001783499
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2015
- Address: c/o Covington & Burling LLP, New York, NY, 10018-1405
- Phone: 734-546-0228

## Officers, directors & promoters (4)

| Name | Role | Location |
| --- | --- | --- |
| Gary Glick | Director | LONDON, X0 |
| David Hoffman | Director | Short Hills, NJ |
| Leonard Oremland | Director | New York, NY |
| David Hoffman | Executive Officer | Short Hills, NJ |

## More

- [CIK 1783499 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1783499&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001783499-19-000005.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.